pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
ensartinib hydrochloride
Ensacove (ensartinib hydrochloride)
Non-Small Cell Lung Cancer
Xcovery Holdings Inc
3 catalysts
Marketed
zongertinib
Hernexeos (zongertinib)
Non-Small Cell Lung Cancer
Boehringer Ingelheim Corp
2 catalysts
Marketed
ET-800
HYDROCORTISONE (hydrocortisone)
Adrenal Insufficiency
$ETONEton Pharmaceuticals, Inc.
3 catalysts
← prev
page 4 of 62
next →
131
Pain89
Neurology1
Marketed
encorafenib
Braftovi (encorafenib)
Metastatic Colorectal Cancer
Array BioPharma Inc
12 catalysts
Marketed
loncastuximab tesirine
Zynlonta (loncastuximab tesirine-lpyl)
Diffuse Large B-Cell Lymphoma
B-lymphocyte antigen CD19
$ADCTADC Therapeutics SA
5 catalysts
Marketed
mogamulizumab
Poteligeo (mogamulizumab)
Peripheral T-Cell Lymphomas (PTCL)
C-C chemokine receptor type 4
Kyowa Kirin Co Ltd
5 catalysts
Marketed
IDELALISIB
IDELALISIB (IDELALISIB)
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
$GILDGILEAD SCIENCES, INC.
1 catalysts
Marketed
(amivantamab + hyaluronidase (human recombinant))
Rybrevant Faspro ((amivantamab + hyaluronidase-rhu (human recombinant)))
Recurrent Head And Neck Squamous Cell Carcinoma
$JNJJOHNSON & JOHNSON
2 catalysts
Marketed
etoposide
Etopophos (etoposide)
Small-Cell Lung Cancer
H2-Pharma LLC
1 catalysts
Marketed
IDARUBICIN HYDROCHLORIDE
IDARUBICIN HYDROCHLORIDE (IDARUBICIN HYDROCHLORIDE)
DNA topoisomerase 2-alpha
$PFEPFIZER INC
15 catalysts
Marketed
ZOLEDRONIC ACID
ZOLEDRONIC ACID (ZOLEDRONIC ACID)
Paget Disease of Bone
Avenacy Inc
22 catalysts
Marketed
HYDROCORTISONE SODIUM SUCCINATE
HYDROCORTISONE SODIUM SUCCINATE (HYDROCORTISONE SODIUM SUCCINATE)
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease)
Cipla USA Inc
1 catalysts
Marketed
LENALIDOMIDE
LENALIDOMIDE (LENALIDOMIDE)
Follicular Lymphoma
CRL4(CRBN) E3 ubiquitin ligase
Bristol-Myers Squibb Co
2 catalysts
Marketed
EPIRUBICIN HYDROCHLORIDE
EPIRUBICIN HYDROCHLORIDE (EPIRUBICIN HYDROCHLORIDE)
Breast Cancer
$AMRXAmneal Pharmaceuticals, Inc.
7 catalysts
Marketed
lorlatinib
Lorbrena (lorlatinib)
Non-Small Cell Lung Cancer
$PFEPFIZER INC
7 catalysts
Marketed
vandetanib
Caprelsa (vandetanib)
Medullary Thyroid Cancer
Genzyme Corp
19 catalysts
Marketed
Imatinib Mesylate Shilpa
Imatinib Mesylate (imatinib mesylate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Armas Pharmaceuticals Inc
46 catalysts
Marketed
ANAGRELIDE HYDROCHLORIDE
ANAGRELIDE HYDROCHLORIDE (ANAGRELIDE HYDROCHLORIDE)
Thrombosis
Takeda Pharmaceuticals USA Inc
3 catalysts
Marketed
TOREMIFENE CITRATE
TOREMIFENE CITRATE (TOREMIFENE CITRATE)
Metastatic Breast Cancer
Rising Pharma Holdings Inc
2 catalysts
Marketed
Bortezomib Pfizer
Bortezomib (bortezomib)
Mantle Cell Lymphoma
Hospira Inc
1 catalysts
Marketed
POMALIDOMIDE
POMALIDOMIDE (POMALIDOMIDE)
Kaposi Sarcoma
Celgene Corp
5 catalysts
Marketed
mosunetuzumab
Lunsumio Velo (mosunetuzumab-axgb)
Diffuse Large B-Cell Lymphoma
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
Genentech Inc
3 catalysts
Marketed
DECITABINE
DECITABINE (DECITABINE)
Chronic Myelomonocytic Leukemia (CMML)
Mylan Institutional Inc
1 catalysts
Marketed
obinutuzumab
Gazyva (obinutuzumab)
Systemic Lupus Erythematosus
B-lymphocyte antigen CD20
F. Hoffmann-La Roche Ltd
14 catalysts
Marketed
rucaparib camsylate
Rubraca (rucaparib camsylate)
Epithelial Ovarian Cancer
PARP 1, 2 and 3
pharmaand GmbH
9 catalysts
Marketed
trastuzumab deruxtecan
Enhertu (fam-trastuzumab deruxtecan-nxki)
Metastatic Colorectal Cancer
Receptor tyrosine-protein kinase erbB-2DNA topoisomerase 1
Daiichi Sankyo Co Ltd
13 catalysts
Marketed
Alimta
Alimta (pemetrexed disodium)
Malignant Pleural Mesothelioma
Lilly USA LLC
3 catalysts
Marketed
NILOTINIB
NILOTINIB (NILOTINIB)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Tyrosine-protein kinase ABL1Bcr/Abl fusion protein
Xspray Pharma AB
1 catalysts
Marketed
(abiraterone acetate + niraparib)
Akeega ((abiraterone acetate + niraparib))
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJJOHNSON & JOHNSON
2 catalysts
Marketed
enzalutamide
Xtandi (enzalutamide)
Prostate Cancer
Alessa Therapeutics Inc
28 catalysts